AB Sciex, Indigo to Market Mass Spec Solutions | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – AB Sciex and Indigo BioSystems today announced an agreement to market mass spectrometry solutions.

The solutions streamline data acquisition and automate data review and are expected to accelerate the use of mass spec technologies by simplifying the workflows. The partnership is also expected to ensure better results in clinical research, forensic toxicology, and pre-clinical and clinical trials of new drugs, AB Sciex and Indigo said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.